Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 3, 2009

Sigma-Aldrich Licenses Polyplus Transfection’s ZNA Oligos for Research Use

  • Sigma-Aldrich negotiated a worldwide license agreement to manufacture and commercialize Polyplus-transfection’s Zip Nucleic Acid (ZNA™) oligonucleotides for research applications. The company points out it will be the first to offer ZNA as custom DNA and RNA oligos to the life science industry.

    ZNA’s are oligonucleotides with attached cationic units. Polyplus claims the cationic residues increases the sensitivity of the oligos and results in increased affinity for nucleic acids without the loss of selectivity. Research applications of ZNAs include their use as PCR probes and primers, for in vitro miRNA detection and inhibition, and for siRNA applications.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »